证券记录 · 已归档季度
MRK
Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
23被追踪持有人
-1Δ持有人
374.82M持有股份
$37.37B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -4.2% ·
股份流向 -0.8% ·
净新建仓位 -4.3%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.91M | $541.94M | n/a | −2 |
| Q2 2026 | 181 | 0 | 1.58B | $203.59B | +4 | −5 |
| Q1 2026 | 185 | +1 | 1.56B | $186.85B | +3 | −3 |
| Q4 2025 | 183 | 0 | 1.68B | $176.48B | +1 | n/a |
| Q3 2025 | 27 | 0 | 972.48M | $81.66B | +1 | −2 |
| Q2 2025 | 25 | 0 | 887.01M | $70.29B | +1 | −1 |
| Q1 2025 | 22 | -1 | 386.62M | $34.78B | n/a | −1 |
| Q4 2024 | 23 | -1 | 374.82M | $37.37B | n/a | −1 |
| Q3 2024 | 23 | +1 | 256.79M | $29.14B | +1 | n/a |
| Q2 2024 | 22 | n/a | 256.16M | $31.70B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 120.91M | n/a | $12.12B | 0.5% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 80.74M | +6.5% | $8.03B | 1.5% | ▲ Add | 3 | SEC ↗ ×9 |
| 3 | Geode Capital Management ✦ (被动) | 61.18M | +3.4% | $6.07B | 0.5% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 34.98M | +3.5% | $3.48B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 16.11M | +9.9% | $1.60B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 12.51M | -44.3% | $1.24B | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 7.91M | -48.1% | $786.58M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 6.47M | -7.0% | $643.94M | 0.5% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 6.37M | -5.7% | $634.17M | 0.7% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Harris Associates (Oakmark) ✦ | 6.24M | +112.2% | $621.20M | 1.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 5.38M | +77.9% | $533.10M | 0.7% | ▲ Add | 3 | SEC ↗ ×6 |
| 12 | Citadel Advisors ✦ | 5.28M | -25.0% | $525.42M | 0.5% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 3.58M | +99.3% | $356.23M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 1.93M | -0.4% | $191.88M | 0.5% | ▼ Trim | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 1.50M | +0.2% | $148.78M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 1.44M | -7.4% | $143.19M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 1.38M | +27.2% | $137.44M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 425.02K | +37.6% | $42.28M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 19 | Fairfax Financial ✦ | 172.90K | 0.0% | $17.20M | 1.1% | Held | 3 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 157.35K | -0.6% | $15.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 79.16K | -2.2% | $7.88M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 60.40K | -9.6% | $6.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 331 | -90.2% | $32,927 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Soros Fund Management | $34.07M | 曾为 1.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3,742 持有人, 1.88B 股份, $215.80B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Guindo Chirfi
Officer · 10.00K 股 · $1.35M
Aug 12
Zachary Jennifer
Officer · 80.31K 股 · $10.72M
Aug 12
DeLuca Richard R.
Officer · 11.10K 股 · $1.46M
Aug 12
DeLuca Richard R.
Officer · 600 股 · $79,222
Aug 11
DeLuca Richard R.
Officer · 5.43K 股 · $718,261
Aug 11
DeLuca Richard R.
Officer · 7.41K 股 · $973,165
Aug 10
DeLuca Richard R.
Officer · 20.78K 股 · $2.71M
Aug 06
DeLuca Richard R.
Officer · 805 股 · $105,472
Aug 06
DeLuca Richard R.
Officer · 4.95K 股 · $643,993
Aug 06
DeLuca Richard R.
Officer · 300 股 · $39,307
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据